FSBEI HE " First Moscow State Medical University n.a. I.M. Sechenov" of the MoH of the RF

Moscow 119992

0 studies enrolling now · 2 studies all time

What they study most

Cancer, Lupus Erythematosus, Systemic

Studies at this site

• Open-Label Extension and Safety Study of Talazoparib — Completed
• Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) — Stopped early